MAPKSP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.131200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.514600E-01
Normal-vs-Stage2
7.882600E-01
Normal-vs-Stage3
3.497000E-01
Normal-vs-Stage4
5.399800E-01
Stage1-vs-Stage2
3.261800E-01
Stage1-vs-Stage3
5.428300E-02
Stage1-vs-Stage4
6.197800E-01
Stage2-vs-Stage3
2.575600E-01
Stage2-vs-Stage4
9.621700E-02
Stage3-vs-Stage4
1.593000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.147200E-01
Normal-vs-AfricanAmerican
9.267600E-01
Normal-vs-Asian
6.475200E-01
Caucasian-vs-AfricanAmerican
9.827200E-01
Caucasian-vs-Asian
5.028000E-01
AfricanAmerican-vs-Asian
6.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.366600E-01
Normal-vs-Female
9.696600E-01
Male-vs-Female
3.232800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.495200E-01
Normal-vs-Age(41-60Yrs)
7.314400E-01
Normal-vs-Age(61-80Yrs)
7.388400E-01
Normal-vs-Age(81-100Yrs)
6.562600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.731800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.722000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.983400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.672170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.544200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.532000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.423600E-01
Normal-vs-Daily Drinker
7.557000E-01
Normal-vs-Weekly Drinker
5.628200E-01
Normal-vs-Occasional Drinker
7.060600E-01
Normal-vs-Social Drinker
9.116000E-01
Non Drinker-vs-Daily Drinker
8.571400E-01
Non Drinker-vs-Weekly Drinker
7.756600E-01
Non Drinker-vs-Occasional Drinker
8.810100E-02
Non Drinker-vs-Social Drinker
3.083600E-01
Daily Drinker-vs-Weekly Drinker
7.010000E-01
Daily Drinker-vs-Occasional Drinker
1.957410E-01
Daily Drinker-vs-Social Drinker
4.572000E-01
Weekly Drinker-vs-Occasional Drinker
9.028000E-02
Weekly Drinker-vs-Social Drinker
3.172600E-01
Occasional Drinker-vs-Social Drinker
7.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.100600E-01
Normal-vs-Grade 2
8.941000E-03
Normal-vs-Grade 3
2.555600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.676800E-01
Grade 1-vs-Grade 3
9.409000E-01
Grade 1-vs-Grade 4
2.100600E-01
Grade 2-vs-Grade 3
6.358200E-01
Grade 2-vs-Grade 4
8.941000E-03
Grade 3-vs-Grade 4
2.555600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.083600E-01
Normal-vs-NonDiabetic
9.764800E-01
Diabetic-vs-NonDiabetic
4.252400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.741800E-01
Normal-vs-NoPancreatitis
9.162400E-01
Pancreatitis-vs-NoPancreatitis
1.135020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.864000E-01
Normal-vs-N1
8.801400E-01
N0-vs-N1
7.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.395800E-01
Normal-vs-TP53-NonMutant
9.696800E-01
TP53-Mutant-vs-TP53-NonMutant
4.839600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
